glp 1 drugs contraindications GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness What ODs Need to Know
Description
Finally, individuals with a history of heart failure, ischaemic heart disease, unstable angina, myocardial infarction, aortic aneurysm or dissection, stroke (ischaemic or haemorrhagic stroke), cerebral infarction, transient ischaemic attack, carotid intervention or surgery, coronary stenting, percutaneous coronary intervention (PCI) or coronary artery bypass before inclusion to the cohort or prior to the index event were also excluded

Pawaskar, M., Tuttle, K
*Individual Results May Vary Houston Weight Loss Center is a physician-supervised medical weight loss clinic serving Houston, Katy, and Webster since 1996

Genetic Variability in GLP-1 Receptor Is Associated with Inter-Individual Differences in Weight Lowering Potential of Liraglutide in Obese Women with PCOS: A Pilot Study. European Journal of Clinical Pharmacology, vol

My rebuttal to that concern comes from the SELECT trial testing Wegovy in patients with heart disease

Finally, beware of compounded GLP-1 drugs, which became popular during a GLP-1 drug shortage starting in 2022
